Uncategorized
Aerie reports $74.4 million net loss in 2015
Aerie Pharmaceuticals reported a GAAP net loss of $74.4 million, or $2.88 per share, in 2015, according to a company press release. In 2014, the GAAP net loss was $48.1 million, or $2 per share.